Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.

• Wefers AK Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. annika.wefers@med.uni-heidelberg.de.
• Stichel D Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Schrimpf D Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Coras R Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany.
• Pages M Department of Neuropathology, Sainte-Anne Hospital, Descartes University, Paris, France.
• Tauziède-Espariat A Department of Neuropathology, Sainte-Anne Hospital, Descartes University, Paris, France.
• Varlet P Department of Neuropathology, Sainte-Anne Hospital, Descartes University, Paris, France.
• Schwarz D Department of Neuroradiology, University Hospital Heidelberg, Heidelberg, Germany.
• Söylemezoglu F Department of Pathology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
• Pohl U Department of Cellular Pathology, Queen's Hospital BHRUT, Romford, UK.
• Pimentel J Department of Neurosciences and Mental Health, Laboratory of Neuropathology, Hospital de Santa Maria (CHULN, EPE), Lisbon, Portugal.
• Meyer J Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Hewer E Institute of Pathology, University of Bern, Bern, Switzerland.
• Japp A Department of Neuropathology, University of Bonn, Bonn, Germany.
• Joshi A Department of Neuropathology, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
• Reuss DE Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Reinhardt A Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Sievers P Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Casalini MB Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Ebrahimi A Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Huang K Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Koelsche C Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Low HL Department of Neurosurgery, Queen's Hospital BHRUT, Romford, UK.
• Rebelo O Neuropathology Unit, Centro Hospitalar de Universidades de Coimbra, Coimbra, Portugal.
• Marnoto D Neuropathology Unit, Centro Hospitalar de Universidades de Coimbra, Coimbra, Portugal.
• Becker AJ Department of Neuropathology, University of Bonn, Bonn, Germany.
• Staszewski O Institute of Neuropathology, University of Freiburg, Freiburg, Germany.
• Mittelbronn M Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt, Germany.
• Hasselblatt M Institute of Neuropathology, University Hospital Münster, Münster, Germany.
• Schittenhelm J Department of Neuropathology, Institute of Pathology and Neuropathology, University Hospital of Tübingen, Tübingen, Germany.
• Cheesman E Department of Paediatric Histopathology, Royal Manchester Children's Hospital Manchester, Manchester, UK.
• de Oliveira RS Division of Pediatric Neurosurgery, Department of Surgery and Anatomy, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
• Queiroz RGP Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
• Valera ET Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.
• Hans VH Abteilung Neuropathologie, Institut für klinische Pathologie, Dietrich-Bonhoeffer-Klinikum, Neubrandenburg, Germany.
• Korshunov A Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Olar A Departments of Pathology and Laboratory Medicine and Neurosurgery, Medical University of South Carolina, Charleston, SC, USA.
• Ligon KL Department of Oncologic Pathology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.
• Pfister SM Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
• Jaunmuktane Z Division of Neuropathology, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
• Brandner S Department of Clinical and Movement Neurosciences, UCL Institute of Neurology, London, UK.
• Tatevossian RG Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
• Ellison DW Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA.
• Jacques TS Developmental Biology and Cancer Section, UCL Great Ormond Street Institute of Child Health, London, UK.
• Honavar M Department of Pathology, Hospital Pedro Hispano, Matosinhos, Portugal.
• Aronica E Amsterdam UMC, Department of (Neuro)Pathology, University of Amsterdam, Amsterdam and Stichting Epilepsie Instellingen Nederland, Heemstede, The Netherlands.
• Thom M Division of Neuropathology, UCL Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK.
• Sahm F Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• von Deimling A Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
• Jones DTW Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
• Blumcke I Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany.
• Capper D Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. david.capper@charite.de.

Epilepsy

Gene fusion

Glioma

Isomorphic diffuse glioma

MYB

MYBL1